You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

~ Buy the PHEXXI (citric acid; lactic acid; potassium bitartrate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR PHEXXI


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for PHEXXI

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01306331 ↗ Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel Completed Health Decisions Phase 3 2011-04-01 This is a research study of a new experimental vaginal gel that helps in vaginal pH regulation and results in immobilization of spermatozoa by maintaining the normally low vaginal pH, even in the presence of semen. This vaginal gel is called Phexxi™ (previously known as Amphora) and was compared to a commercially available spermicide called Conceptrol®, which contains nonoxynol 9; commonly abbreviated as N-9. Conceptrol® can help prevent pregnancy. This study objective was to determine if this product prevents pregnancy when inserted into the vagina before intercourse.
NCT01306331 ↗ Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel Completed Evofem Inc. Phase 3 2011-04-01 This is a research study of a new experimental vaginal gel that helps in vaginal pH regulation and results in immobilization of spermatozoa by maintaining the normally low vaginal pH, even in the presence of semen. This vaginal gel is called Phexxi™ (previously known as Amphora) and was compared to a commercially available spermicide called Conceptrol®, which contains nonoxynol 9; commonly abbreviated as N-9. Conceptrol® can help prevent pregnancy. This study objective was to determine if this product prevents pregnancy when inserted into the vagina before intercourse.
NCT03243305 ↗ AMP002 Phase III Contraceptive Study Completed Parexel Phase 3 2017-07-24 This is a single-arm, open-label, Phase III study in approximately 100 sites in the United States (US) over seven cycles of use in women aged 18 to 35 years who are at risk of pregnancy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for PHEXXI

Condition Name

Condition Name for PHEXXI
Intervention Trials
Contraception 2
Vulvovaginal Candidiasis 1
Bacterial Vaginosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for PHEXXI
Intervention Trials
Vaginosis, Bacterial 1
Candidiasis, Vulvovaginal 1
Candidiasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for PHEXXI

Trials by Country

Trials by Country for PHEXXI
Location Trials
United States 49
Russian Federation 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for PHEXXI
Location Trials
Washington 2
Utah 2
Texas 2
Pennsylvania 2
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for PHEXXI

Clinical Trial Phase

Clinical Trial Phase for PHEXXI
Clinical Trial Phase Trials
Phase 3 2
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for PHEXXI
Clinical Trial Phase Trials
Completed 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PHEXXI

Sponsor Name

Sponsor Name for PHEXXI
Sponsor Trials
Evofem Inc. 2
Health Decisions 1
Parexel 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for PHEXXI
Sponsor Trials
Other 3
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.